aod9604 peptide dosing protocol December 4, 2024 Pharmacy Compounding Advisory Committee (PCAC) Meeting AOD-9604 Dosage Chart – 2
Description
Syringes and needles for injection ordered separately
Unlike full-length growth hormone, AOD-9604 selectively targets fat metabolism through beta-3 adrenergic receptor pathways without affecting insulin sensitivity or IGF-1 levels
Conclusion The combination of NAD+ and 5-Amino-1MQ is still relatively new, but its potential is groundbreaking
The conditional amino acids include
Departure: many patients are back out the door in about 15 minutes
